These results suggest that MRPL37 may promote immune escape in HCC, potentially through the regulation of immune checkpoint molecules like PD-L1, which inhibit T cell activation and function, thereby evading immune surveillance. This evidence concerns the gene MRPL37 and hepatocellular carcinoma.